" class="no-js "lang="en-US"> Jeremy Perkins - Medtech Alert
Saturday, December 14, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Jeremy Perkins

Jeremy Perkins

About Jeremy Perkins

Jeremy was the Winner of the 40 under 40 Awards for most influential leaders in Sacramento region in 2015 & voted the Top 4 Most Admired CEO in Sacramento.

Specialties: Orthopedics, Spine, Podiatry, DME, ASC market, and hospital accounts. We provide cost saving consulting for Hospitals, ambulatory surgery centers, urgent care facilities, and private clinics. Consulting.

Related Story

Appointments

 Precision Medical Products

Precision Medical Products, Inc. Announces Steve Ingel As New CEO

April 14 2022

Precision Medical Products today announced the appointment of Steven Ingel to President & CEO of Precision Medical […]